RxDoctor Payments Data

Dmitriy Zubkus, MD

Critical Care Medicine · Orlando, FLNPI 1871704221

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $19,245 of the $21,945 with a category attached, or 87.7%. Actelion Pharmaceuticals US, Inc. accounts for 97.7% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $16,291 and has fallen 99.9% since, to $21 in 2023. Among critical care medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$21,945in general payments, 2019–2025

Across 41 payments — averaging $535.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Actelion Pharmaceuticals US, Inc.$21K
  • United Therapeutics Corporation$326
  • Abiomed$125
  • Regeneron Healthcare Solutions, Inc.$21
  • Mylan Specialty L.p.$20
  • Getinge USA Sales, LLC$19
$24,150in research payments, 2019–2025

Across 15 payments — averaging $1610.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Actelion Pharmaceuticals US, Inc.$13K
  • Actelion Pharmaceuticals, Ltd$8K
  • Janssen Research & Development, LLC$3K

What the payments were for

  • Speaking & faculty fees$19,24588%
  • Travel & lodging$1,8869%
  • Food & beverage$7844%
  • Education$300%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,945 in reported general payments places this provider in the 95th percentile of 618 critical care medicine providers in Florida.

See all critical care medicine providers in Florida

Medicare billing

Part B allowed, 2024
$49,772
Medicare patients
142
Services billed
334

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other critical care medicine in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →